OptiBiotix Health (LON:OPTI) Hits New 12-Month Low – Here’s What Happened

Shares of OptiBiotix Health Plc (LON:OPTI) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 6.50 and last traded at GBX 6.89, with a volume of 8091 shares traded. The stock had previously closed at GBX 6.75.

OptiBiotix Health Trading Up 2.1%

The company’s fifty day simple moving average is GBX 7.80 and its 200-day simple moving average is GBX 9.94. The stock has a market cap of £7.12 million, a P/E ratio of -229.67 and a beta of 1.71.

Insider Activity at OptiBiotix Health

In related news, insider David Blain bought 84,053 shares of OptiBiotix Health stock in a transaction dated Wednesday, October 1st. The shares were bought at an average cost of GBX 1,175 per share, for a total transaction of £987,622.75. Insiders own 26.82% of the company’s stock.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.